PDF herunterladen
Horm Metab Res 2022; 54(06): 361-370
DOI: 10.1055/a-1853-9889
Original Article: Endocrine Care

Triglyceride-Glucose Index and the Prognosis of Patients with Acute Ischemic Stroke: A Meta-Analysis

Xueling Ma
1   Department of Neurology, Fourth Hospital of Harbin Medical University, Harbin, China
,
Yuijia Han
2   Department of Neurology, Beidahuang Group General Hospital, Harbin, China
,
Lai Jiang
2   Department of Neurology, Beidahuang Group General Hospital, Harbin, China
,
Man Li
1   Department of Neurology, Fourth Hospital of Harbin Medical University, Harbin, China
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

A higher triglyceride-glucose (TyG) index has been related to an increased incidence of stroke in community population. A meta-analysis was performed to evaluate the association between TyG index and prognosis in patients with acute ischemic stroke (IS). Observational studies, which evaluated the influence of TyG index on functional outcome and mortality in patients with acute IS were retrieved by search the PubMed, Embase, Web of Science, Wanfang and China National Knowledge Infrastructure databases from inception to February 20, 2022. Two authors independently collected the data of study characteristics and outcomes. A random-effect model was used to pool the results via incorporating the influence of possible between-study heterogeneity. Eight cohort studies involving 34 076 patients with acute IS contributed to the study. Pooled results showed that a higher TyG index was independently associated with increased risks of all-cause mortality (OR: 1.60, 95% CI: 1.19–2.15, p=0.002; I2=78%) and poor functional outcome (OR: 1.37, 95% CI: 1.11–1.69, p=0.004; I2=71%). Further sensitivity analyses by excluding one cohort study at a time showed consistent results (p all<0.05). Subgroup analyses showed similar results in prospective and retrospective cohort studies, in non-diabetic and diabetic patients, and in studies with follow-up durations within 3 months and of 12 months (p for subgroup analyses all>0.05). In conclusion, higher TyG index is a predictor of all-cause mortality and poor functional outcome in patients with acute IS, and TyG index may be useful for prognostic evaluation in these patients.

Key words

triglyceride-glucose index - insulin resistance - ischemic stroke - mortality - meta-analysis


Publikationsverlauf

Eingereicht: 17. April 2022

Angenommen: 06. Mai 2022

Artikel online veröffentlicht:
13. Juni 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Tsao CW, Aday AW, Almarzooq ZI. et al. Heart disease and stroke statistics-2022 update: a report from the American heart association. Circulation 2022; 145: e153-e639
    PubMedGoogle Scholar
  • 2 Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology 2021; 97: S6-S16
    CrossrefPubMedGoogle Scholar
  • 3 Jolugbo P, Ariens RAS. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke 2021; 52: 1131-1142
    CrossrefPubMedGoogle Scholar
  • 4 Rabinstein AA. Treatment ofacute ischemic stroke. Continuum (Minneap Minn) 2017; 23: 62-81
    PubMedGoogle Scholar
  • 5 Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ 2020; 368: l6983
    CrossrefPubMedGoogle Scholar
  • 6 Montellano FA, Ungethum K, Ramiro L. et al. Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke 2021; 52: 543-551
    CrossrefPubMedGoogle Scholar
  • 7 Fahey M, Crayton E, Wolfe C. et al. Clinical prediction models for mortality and functional outcome following ischemic stroke: a systematic review and meta-analysis. PLoS One 2018; 13: e0185402
    CrossrefPubMedGoogle Scholar
  • 8 Hill MA, Yang Y, Zhang L. et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism 2021; 119: 154766
    CrossrefPubMedGoogle Scholar
  • 9 Di Pino A, DeFronzo RA. Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents. Endocr Rev 2019; 40: 1447-1467
    CrossrefPubMedGoogle Scholar
  • 10 Muniyappa R, Lee S, Chen H. et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294: E15-E26
    CrossrefPubMedGoogle Scholar
  • 11 Sanchez-Garcia A, Rodriguez-Gutierrez R. et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol 2020; 4678526
    PubMedGoogle Scholar
  • 12 Brito ADM, Hermsdorff HHM, Filgueiras MS. et al. Predictive capacity of triglyceride-glucose (TyG) index for insulin resistance and cardiometabolic risk in children and adolescents: a systematic review. Crit Rev Food Sci Nutr 2021; 61: 2783-2792
    CrossrefPubMedGoogle Scholar
  • 13 Feng X, Yao Y, Wu L. et al. Triglyceride-glucose index and the risk of stroke: a systematic review and dose-response meta-analysis. Horm Metab Res 2022; 54: 175-186
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 14 Ding X, Wang X, Wu J. et al. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol 2021; 20: 76
    CrossrefPubMedGoogle Scholar
  • 15 Zhang B, Liu L, Ruan H. et al. Triglyceride-glucose index linked to hospital mortality in critically ill Stroke: an observational multicentre study on eICU database. Front Med (Lausanne) 2020; 7: 591036
    CrossrefPubMedGoogle Scholar
  • 16 Zhou Y, Pan Y, Yan H. et al. Triglyceride glucose index and prognosis of patients with ischemic stroke. Front Neurol 2020; 11: 456
    CrossrefPubMedGoogle Scholar
  • 17 Hou Z, Pan Y, Yang Y. et al. An analysis of the potential relationship of triglyceride glucose and body mass index with stroke prognosis. Front Neurol 2021; 12: 630140
    CrossrefPubMedGoogle Scholar
  • 18 Lee M, Kim CH, Kim Y. et al. High triglyceride glucose index is associated with poor outcomes in ischemic stroke patients after reperfusion therapy. Cerebrovasc Dis 2021; 50: 691-699
    CrossrefPubMedGoogle Scholar
  • 19 Xie Y, Gao XY, Li L. et al. Predictive value of TyG index in prognosis of senile patients with major atherosclerotic stroke. J Med Res 2021; 50: 141-145
    PubMedGoogle Scholar
  • 20 Lin SF, Hu HH, Chao HL. et al. Triglyceride-glucose index and intravenous thrombolysis outcomes for acute ischemic stroke: a multicenter prospective-cohort study. Front Neurol 2022; 13: 737441
    CrossrefPubMedGoogle Scholar
  • 21 Toh EMS, Lim AYL, Ming C. et al. Association of triglyceride-glucose index with clinical outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis. Sci Rep 2022; 12: 1596
    CrossrefPubMedGoogle Scholar
  • 22 Yang X, Wang G, Jing J. et al. Association of triglyceride-glucose index and stroke recurrence among nondiabetic patients with acute ischemic stroke. BMC Neurol 2022; 22: 79
    CrossrefPubMedGoogle Scholar
  • 23 Page MJ, Moher D, Bossuyt PM. et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021; 372 n160
    PubMedGoogle Scholar
  • 24 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 n71
    PubMedGoogle Scholar
  • 25 Higgins J, Thomas J, Chandler J. et al. Cochrane handbook for systematic reviews of interventions version 6.2. The Cochrane Collaboration. 2021 www.training.cochrane.org/handbook
    PubMedGoogle Scholar
  • 26 Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6: 299-304
    CrossrefPubMedGoogle Scholar
  • 27 Wang S, Lv Y, Zheng X. et al. The impact of cerebral microbleeds on intracerebral hemorrhage and poor functional outcome of acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis. J Neurol 2017; 264: 1309-1319
    CrossrefPubMedGoogle Scholar
  • 28 Wells GA, Shea B, O’Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010 http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
    PubMed
  • 29 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
    Google Scholar
  • 30 Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008; 37: 1148-1157
    CrossrefPubMedGoogle Scholar
  • 31 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
    Google Scholar
  • 32 Matulewicz N, Karczewska-Kupczewska M. Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online) 2016; 70: 1245-1258
    PubMedGoogle Scholar
  • 33 Ormazabal V, Nair S, Elfeky O. et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 2018; 17: 122
    CrossrefPubMedGoogle Scholar
  • 34 Maciejczyk M, Zebrowska E, Chabowski A. Insulin resistance and oxidative stress in the brain: What’s New?. Int J Mol Sci 2019; 20: 874
    CrossrefPubMedGoogle Scholar
  • 35 Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a meta-analysis. Front Cardiovasc Med 2021; 8: 644035
    CrossrefPubMedGoogle Scholar
  • 36 Pranata R, Huang I, Irvan et al. The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus-a systematic review and dose-response meta-analysis of cohort studies. Endocrine 2021; 74: 254–262
    PubMed
  • 37 Nam KW, Kang MK, Jeong HY. et al. Triglyceride-glucose index is associated with early neurological deterioration in single subcortical infarction: Early prognosis in single subcortical infarctions. Int J Stroke 2021; 16: 944-952
    CrossrefPubMedGoogle Scholar
  • 38 Nam KW, Kwon HM, Lee YS. High triglyceride-glucose index is associated with early recurrent ischemic lesion in acute ischemic stroke. Sci Rep 2021; 11: 15335
    CrossrefPubMedGoogle Scholar
  • 39 Guo Y, Zhao J, Zhang Y. et al. Triglyceride glucose index influences platelet reactivity in acute ischemic stroke patients. BMC Neurol 2021; 21: 409
    CrossrefPubMedGoogle Scholar
  • 40 Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M. et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3347-3351
    CrossrefPubMedGoogle Scholar
  • 41 Vasques AC, Novaes FS, de Oliveira Mda S. et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011; 93: e98-e100
    CrossrefPubMedGoogle Scholar
  • 42 Kim JA, Hwang SY, Yu JH. et al. Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008-2011. Sci Rep 2021; 11: 450
    CrossrefPubMedGoogle Scholar
  • 43 Sanchez-Escudero V, Garcia Lacalle C, Gonzalez Vergaz A. et al. The triglyceride/glucose index as an insulin resistance marker in the pediatric population and its relation to eating habits and physical activity. Endocrinol Diabetes Nutr (Engl Ed) 2021; 68: 296-303
    PubMedGoogle Scholar